background
glioblastoma
frequent
malign
primari
brain
tumor
poor
prognosi
translat
therapeut
strategi
glioblastoma
experiment
phase
clinic
limit
insuffici
anim
model
lack
import
featur
human
tumor
lentivir
gene
therapi
attract
therapeut
option
human
glioblastoma
valid
clinic
relev
anim
model
use
rodent
xenograft
model
recapitul
invas
angiogen
featur
human
glioblastoma
analyz
transduct
pattern
therapeut
efficaci
lentivir
pseudotyp
vector
lymphocyt
choriomening
viru
glycoprotein
lcmvgp
vesicular
stomat
viru
glycoprotein
vsvg
pseudotyp
lentivir
vector
effici
transduc
human
glioblastoma
cell
vitro
vivo
contrast
pseudotyp
gammaretrovir
vector
similar
evalu
clinic
therapi
glioblastoma
show
ineffici
gene
transfer
vitro
vivo
pseudotyp
lentivir
vector
transduc
cancer
stemlik
cell
character
nestinand
abil
form
spheroid
neural
stem
cell
medium
express
astrocyt
neuron
differenti
marker
serum
condit
therapeut
approach
use
suicid
gene
herp
simplex
viru
thymidin
kinas
fuse
egfp
lentivir
vector
mediat
complet
remiss
solid
tumor
seen
mri
result
highli
signific
surviv
benefit
compar
control
group
recurr
tumor
surviv
egfpposit
tumor
cell
found
advoc
prodrug
applic
sever
cycl
even
enhanc
prolong
therapeut
effect
conclusionssignific
conclus
lentivir
pseudotyp
vector
promis
candid
gene
therapi
glioma
patient
ineffici
gene
deliveri
gammaretrovir
vector
line
result
obtain
clinic
therapi
gbm
thu
confirm
high
reproduc
invas
glioma
anim
model
translat
research
glioblastoma
frequent
malign
primari
brain
tumor
despit
advanc
neurosurgeri
radiat
chemotherapi
prognosi
patient
remain
poor
median
surviv
month
major
drawback
translat
brain
cancer
research
lack
suitabl
anim
model
syngeneicor
xenograft
tumor
base
glioblastoma
cell
line
cultur
monolay
grow
circumscrib
highli
angiogen
lesion
vivo
lack
invas
tumor
cell
repres
import
featur
human
glioblastoma
invas
cell
migrat
away
initi
tumor
mass
caus
recurr
tumor
differ
region
brain
thu
cell
repres
major
therapeut
target
recent
establish
model
glioblastoma
biopsybas
spheroid
serial
passag
brain
nude
rat
show
highli
invas
angiogen
featur
therefor
model
well
suit
studi
new
therapeut
strategi
still
report
use
clinic
relev
model
experiment
therapi
scarc
recent
analyz
therapeut
potenti
oncolyt
herp
vector
biopsi
spheroidbas
gbm
model
tumor
volum
treat
anim
reduc
compar
control
group
signific
surviv
advantag
contrast
therapi
effect
cell
linebas
anim
model
result
current
investig
phase
iii
clinic
studi
present
investig
use
invas
xenograft
model
evalu
transduct
therapeut
efficaci
lentivir
pseudotyp
vector
gammaretrovir
vector
deriv
moloney
murin
leukemia
viru
mmlv
frequent
use
retrovirus
gene
therapi
brain
tumor
howev
despit
promis
result
anim
model
clinic
trial
use
retrovir
vector
supernat
retrovir
packag
cell
fail
one
major
drawback
gammaretrovir
vector
exclus
transduct
divid
cell
sinc
human
glioma
major
tumor
cell
divid
within
given
treatment
window
therefor
lentivir
vector
abil
also
transduc
nondivid
cell
attract
candid
treatment
brain
cancer
previou
studi
develop
gammaretrovir
lentivir
vector
pseudotyp
glycoprotein
gp
lymphocyt
choriomening
viru
lcmv
vector
broad
host
rang
concentr
ultracentrifug
vivo
applic
addit
lcmvgp
cytotox
stabl
recombin
packag
cell
line
establish
recent
show
lentivir
lcmvgp
pseudotyp
effici
deliv
transgen
rat
glioma
cell
vivo
resid
neuron
transduc
furthermor
show
signific
therapeut
effect
lcmvgp
pseudotyp
lentivir
vector
celllin
base
rat
glioma
model
use
suicid
gene
vsvg
lentivir
pseudotyp
also
show
signific
efficaci
similar
lcmv
pseudotyp
mainli
mediat
bystand
effect
transduc
normal
brain
cell
present
work
show
vsvg
lcmvgp
pseudotyp
lentivirus
effici
transduc
human
glioma
cell
vitro
vivo
wherea
gammaretrovir
transduct
ineffici
gene
transfer
glioma
cell
effici
lentivir
pseudotyp
vector
type
howev
specif
use
lcmvgp
pseudotyp
vector
vsvg
pseudotyp
also
transduc
host
brain
cell
invas
area
analysi
transduc
tumor
cell
reveal
lentivir
vector
target
well
cancer
cell
furthermor
transduc
glioblastoma
cell
express
stem
cell
marker
nestin
importantli
evalu
therapeut
applic
use
transgen
lentivir
vector
mediat
complet
tumor
regress
mri
result
highli
signific
surviv
benefit
compar
control
group
collect
human
biopsi
tissu
approv
region
ethic
committe
handl
anim
surgic
procedur
done
accord
norwegian
anim
act
local
ethic
committe
approv
protocol
human
embryon
kidney
cell
line
atcc
number
cell
line
obtain
american
type
cultur
collect
atcc
manassa
va
maintain
dulbbeco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
glutamin
cell
line
grown
humidifi
atmospher
co
tumor
fragment
glioblastoma
multiform
patient
obtain
surgeri
tissu
specimen
taken
viabl
tumor
area
correspond
region
contrast
enhanc
preoper
mriscan
specimen
transfer
test
tube
contain
complet
growth
medium
spheroid
prepar
previous
describ
method
appli
tumor
materi
passag
nude
rat
briefli
tissu
sampl
minc
mm
fragment
place
cm
tissu
cultur
flask
nunc
roskild
denmark
baseco
agar
difco
detroit
mi
spheroid
maintain
standard
tissu
cultur
incub
co
rel
humid
medium
chang
week
spheroid
diamet
mm
select
vitro
experi
intracerebr
implant
tumor
dissoci
use
neuron
dissoci
kit
miltenyi
bergischgladbach
germani
accord
manufactur
protocol
cell
analyz
sort
moflo
cell
sorter
beckman
coulter
usa
former
cytom
usa
equip
coher
enterpris
argonion
laser
tune
nm
use
mw
nm
diod
mw
two
mgml
propidium
iodid
pi
molecular
probe
ad
sampl
flow
sort
facilit
dead
cell
discrimin
gfp
pi
excit
nm
fluoresc
measur
bp
bp
optic
filter
filter
omega
optic
brattleboro
vt
usa
respect
doublet
discrimin
use
forward
light
scatter
fsc
versu
puls
width
channel
logarithm
mode
fsc
use
display
gate
pi
positivedead
cell
fsc
side
light
scatter
ssc
signal
detect
shown
linear
mode
gfp
cell
defin
ssc
versu
logarithm
mode
dot
plot
exclus
dead
cell
debri
describ
analysi
express
cell
stain
allophycocyanin
apc
conjug
monoclon
antibodi
miltenyi
bergischgladbach
germani
accord
manufactur
gener
protocol
immunofluoresc
stain
min
dark
excit
nm
fluoresc
measur
bp
optic
filter
aliv
cell
defin
ssc
versu
logarithm
mode
dot
plot
nonstain
cell
suspens
use
control
gfp
tumor
cell
sort
purifi
mode
polypropylen
roundbottom
falcon
tube
becton
dickinson
labwar
europ
franc
contain
cultur
media
place
ice
aliquot
sampl
end
sort
remov
reanalyz
control
sort
puriti
greater
sort
cell
either
cultur
neurobas
medium
invitrogen
carlsbad
ca
supplement
mlml
invitrogen
glutamax
mlml
invitrogen
fibroblast
growth
factor
ngml
peprotech
rocki
hill
nj
epiderm
growth
factor
ng
ml
peprotech
transfer
dmem
supplement
fetal
calf
serum
fc
glutamin
grown
cover
slip
well
plate
immunofluoresc
stain
spheroidsadher
cell
spheroidsadher
cell
stain
humanspecif
mouseantinestin
antibodi
millipor
billerica
antibodi
r
millipor
antibodi
mouseantigfap
antibodi
millipor
primari
antibodi
incub
overnight
und
antibodi
dianova
hamburg
germani
use
secondari
antibodi
night
spheroid
room
temperatur
adher
cell
spheroid
examin
fluoresc
microscop
nikon
tokyo
japan
adher
cell
analyz
confoc
scan
laser
microscopi
zeiss
jena
germani
lentivir
vector
plasmid
prrlsincmvegfppr
publish
naldini
et
al
construct
lentivir
vector
prrlsincmvtkegfppr
describ
previous
retrovir
vector
describ
previous
cell
line
use
transient
lentivir
vector
product
lentivir
vector
plasmid
prrlsincmvtk
egfppr
mg
prrlsincmvegfppr
mg
hiv
gagpolrev
express
plasmid
mg
mg
envelop
express
plasmid
phcmvlcmvgp
pcmvg
cotransfect
cell
concentr
describ
previous
product
retrovir
vector
cell
transfect
mg
mg
psvmomlvgagpol
mg
envelop
express
plasmid
phcmvlcmvgp
pcmvg
vector
harvest
concentr
describ
previous
vector
titer
cell
describ
previous
intracrani
implant
glioblastoma
spheroid
done
describ
previous
three
week
one
month
implant
anim
anesthet
prepar
vector
inject
skin
withdrawn
reveal
locat
craniotomi
time
ml
vector
stock
deliv
centr
tumor
use
glass
syring
model
hamilton
bonaduz
switzerland
secur
microprocessorcontrol
infus
pump
ump
world
precis
instrument
aston
stevenag
uk
inject
coordin
estim
analyz
mri
imag
individu
lesion
vector
infus
done
convect
enhanc
deliveri
cours
min
nlmin
min
follow
nlmin
min
final
nl
min
min
infus
needl
left
place
min
avoid
vector
reflux
needl
slowli
retract
skinfold
close
polyamid
surgic
thread
follow
surgeri
rat
allow
recov
incub
set
return
cage
rat
bear
glioblastoma
xenograft
treat
daili
ip
inject
mgkg
ganciclovir
gcv
roch
basel
switzerland
anim
euthan
perfus
steril
salin
thereaft
paraformaldehyd
brain
remov
suspend
sucros
three
day
snap
frozen
isopentan
chill
dri
ice
coron
section
mm
prepar
cryostat
immunofluoresc
analysi
section
stain
humanspecif
antinestin
antibodi
millipor
human
glioblastoma
cell
mouseantineun
millipor
antibodi
neuron
rat
specif
mouseantinestin
antibodi
millipor
astrocyt
progenitor
cell
primari
antibodi
dilut
incub
overnight
biotinyl
goatantimous
goatantirabbit
vector
laboratori
burlingham
ca
use
secondari
antibodi
dilut
h
room
temperatur
section
incub
sigma
st
loui
mo
fluorochrom
dilut
h
room
temperatur
section
examin
fluoresc
microscop
nikon
analyz
confoc
scan
laser
microscopi
zeiss
jena
germani
analysi
transduct
efficaci
consecut
section
everi
throughout
tumor
examin
fluoresc
microscop
nikon
autom
stage
use
transduct
volum
calcul
use
nikon
lucia
imag
softwar
paraffin
embed
formalinfix
tissu
section
rat
brain
patient
materi
place
xylen
bath
minut
absolut
ethanol
minut
ethanol
minut
final
distil
water
second
remov
paraffin
rehydr
epitop
retriev
perform
heat
section
minut
mm
citrat
buffer
ph
section
incub
monoclon
humanspecif
antinestin
antibodi
bsa
night
biotinyl
goatantimous
antibodi
vector
laboratori
use
secondari
antibodi
dilut
h
room
temperatur
follow
abccomplex
incub
min
section
develop
dako
cytom
follow
manufactur
instruct
use
bruker
pharmascan
tesla
mr
scanner
bruker
biospin
billerica
axial
rare
sequenc
acquir
repetit
time
ms
echo
time
ms
slice
thick
mm
field
view
cm
matrix
size
slice
scan
anim
kept
anesthesia
isofluoran
scheringplough
kenilworth
nj
mix
air
surviv
analyz
logrank
test
base
kaplanmei
test
use
spss
softwar
differ
pair
group
determin
student
ttest
p
consid
signific
human
glioblastoma
spheroid
deriv
either
directli
patient
low
gener
serial
vivo
passag
brain
nude
rat
high
gener
infect
lentivir
lcmvgp
ml
vsvg
pseudotyp
lentivir
vector
particl
ml
retrovir
mlvbase
vector
pseudotyp
lcmvgp
particl
ml
vector
prepar
way
vitro
vivo
experi
see
materi
method
lentivir
vector
transduc
patient
spheroid
high
gener
spheroid
effici
figur
contrast
retrovir
vector
transduc
singl
cell
high
gener
spheroid
figur
fail
transduc
patient
spheroid
data
shown
conclus
lentivir
vector
much
effici
transduc
human
glioblastoma
spheroid
vitro
retrovir
vector
compar
transduct
effici
lentivir
gammaretrovir
vector
vivo
use
xenograft
model
reflect
angiogen
invas
featur
human
glioblastoma
situ
xenograft
also
express
neural
progenitor
marker
nestin
close
recapitul
histolog
patient
tumor
figur
vector
inject
center
progress
grow
lesion
use
microprocessorcontrol
stereotact
infus
inject
coordin
estim
analyz
mri
imag
individu
lesion
inject
volum
appli
ml
vector
titr
ml
vector
transduct
effici
evalu
day
vector
inject
lentivir
pseudotyp
vector
show
effici
transduct
tumor
figur
analyz
higher
magnif
lcmvgp
vsvg
pseudotyp
lentivir
vector
show
effici
transgen
deliveri
nestinposit
tumor
cell
solid
figur
e
invas
tumor
area
figur
f
contrast
retrovir
vector
transduc
scatter
tumor
cell
near
inject
site
figur
g
h
quantit
comparison
transduct
effici
two
lentivir
pseudotyp
vector
gfpposit
area
measur
histolog
slide
see
materi
method
total
volum
transduc
tumor
tissu
mm
lcmvgp
pseudotyp
vector
mm
vsvg
pseudotyp
vector
figur
although
differ
mean
statist
signific
p
due
high
interindividu
differ
standard
deviat
analyz
transduct
specif
histolog
section
invas
tumor
area
stain
rat
specif
marker
neun
neuron
nestin
astrocyt
progenitor
cell
lcmvgp
pseudotyp
lentivir
vector
exclus
transduc
tumor
cell
invas
area
figur
normal
brain
cell
transduc
figur
c
also
vsvg
pseudotyp
vector
show
specif
transduct
tumor
cell
invas
area
figur
e
howev
also
transduc
host
brain
cell
site
figur
h
analyz
potenti
lentivir
vector
infect
cancer
stemlik
cell
transduc
tumor
enzymat
dissoci
express
measur
flow
cytometri
vector
transduc
cell
figur
although
high
interindividu
differ
fraction
total
tumor
cell
differ
xenograft
vector
show
similar
effici
transduc
cell
slightli
higher
overal
fraction
cell
tabl
gfpposit
cell
tumor
transduc
lcmvgp
vsvg
pseudotyp
lentivir
vector
sort
cultur
neural
basal
medium
supplement
egf
bfgf
transduc
tumor
cell
vector
abl
form
spheroid
figur
e
spheroid
express
stem
cell
marker
nestin
figur
f
g
sort
cell
also
plate
serum
condit
cell
continu
show
signific
express
stem
cell
marker
nestin
also
differenti
marker
gfap
btubuliniii
figur
evalu
therapeut
efficaci
lentivir
pseudotyop
vector
invas
xenograft
model
vector
express
suicid
gene
fuse
egfp
inject
establish
tumor
visibl
mri
use
method
describ
vivo
tropism
studi
anim
treat
daili
mgkg
ganciclovir
day
start
day
post
vector
inject
tumor
growth
measur
everi
day
mri
week
treatment
anim
lcmvand
vsvpseudotyp
treat
group
complet
remiss
mri
figur
one
anim
group
stabl
diseas
end
gc
treatment
anim
control
group
develop
larg
tumor
treatment
period
day
figur
lcmvand
vsvpseudotyp
treat
anim
highli
signific
surviv
advantag
compar
control
group
figur
statist
signific
differ
surviv
two
treatment
group
upon
cessat
prodrug
administr
anim
develop
recurr
tumor
could
classifi
three
differ
group
figur
tabl
anim
show
either
local
recurr
local
andor
contralater
recurr
recurr
distant
brain
area
clear
differ
recurr
pattern
two
vector
type
lcmvpseudotyp
vectortr
anim
contralater
recurr
wherea
vsvg
pseudotyp
vectortr
anim
local
recurr
figur
e
tabl
histopatholog
confoc
microscop
analysi
lesion
reveal
gfpposit
cell
recurr
tumor
demonstr
transduc
glioma
cell
kill
ganciclovir
treatment
figur
vsvg
pseudotypetr
anim
gfpposit
surviv
cell
found
invas
area
figur
g
corpu
callosum
region
figur
also
region
distant
recurr
one
anim
also
show
focu
transduc
normal
brain
cell
tumor
border
surviv
gc
treatment
figur
lcmv
group
gfpposit
cell
found
ipsilater
hemispher
solid
invas
tumor
area
figur
k
l
cell
seen
contralater
hemispher
figur
futur
success
glioma
gene
therapi
depend
potent
vector
system
show
higher
transduct
effici
system
avail
today
addit
applic
repres
anim
model
recapitul
invas
angiogen
featur
patient
tumor
vital
order
minim
huge
discrep
experiment
result
clinic
outcom
previous
observ
gene
therapeut
strategi
brain
cancer
end
appli
one
clinic
relev
anim
model
glioblastoma
known
model
establish
sever
year
ago
growth
pattern
well
genoand
phenotyp
similar
glioblastoma
patient
extens
character
strike
differ
model
compar
celllin
base
model
highli
invas
behaviour
lesion
similar
glioblastoma
patient
model
base
spheroid
deriv
patient
biopsi
passag
serial
brain
nude
rat
first
gener
tumor
highli
invas
grow
without
sign
angiogenesi
late
gener
tumor
show
angiogen
phenotyp
still
invas
vitro
experi
reveal
lentivir
vector
transduc
spheroid
deriv
low
high
gener
tumor
effici
contrast
retrovir
vector
transduc
high
gener
spheroid
display
much
lower
effici
gene
transfer
lentivir
vector
differ
attribut
vector
backbon
glycoprotein
respons
viru
entri
cell
retrovir
one
lentivr
vector
appli
lcmvgp
import
featur
distinguish
lentivir
retrovir
vector
abil
infect
nondivid
cell
known
glioma
spheroid
especi
primari
biopsi
spheroid
contain
signific
fraction
nondivid
cell
transduc
retrovir
vector
previous
shown
cultur
biopsi
spheroid
show
similar
cell
prolifer
seen
glioblastoma
patient
previou
studi
demonstr
retrovir
vector
effici
transduc
highli
prolif
monolay
cultur
glioma
cell
line
howev
monolay
cultur
chang
genoand
phenotyp
characterist
long
term
cultur
thu
suitabl
model
answer
clinic
relev
question
vivo
experi
select
high
gener
xenograft
show
angiogen
invas
featur
recapitul
histolog
patient
lesion
furthermor
xenograft
show
high
level
nestin
express
similar
patient
materi
translat
research
crucial
assur
experiment
tumor
truli
reflect
correspond
patient
tumor
properti
avoid
use
nonrelev
anim
model
howev
strategi
common
practic
yet
base
simplic
use
establish
cell
line
vivo
experi
show
high
transduct
effici
lentivir
vector
glioma
cell
vivo
wherea
retrovir
vector
transduc
scatter
tumor
cell
near
inject
track
contrast
vivo
studi
other
retrovir
vector
effici
mention
model
appli
noninvas
base
cell
line
cultur
monolay
note
result
clinic
studi
use
retrovir
vector
show
low
transduct
effici
observ
model
system
find
provid
evid
glioma
model
use
higher
predict
valu
perform
novel
therapeut
approach
clinic
previou
anim
model
tropism
glioma
cell
specif
lcmvgp
lentivir
pseudotyp
vector
vsvg
pseudotyp
lentivir
vector
also
transduc
normal
brain
cell
invas
area
previou
studi
use
rat
glioma
model
also
show
specif
transduct
glioma
cell
lcmvgp
pseudotyp
vector
compar
vsvg
pseudotyp
vector
fact
studi
vsvg
pseudotyp
vector
transduc
normal
brain
cell
much
higher
frequenc
studi
explain
mode
vector
deliveri
previou
studi
inject
vector
tumor
core
well
tumor
border
area
present
studi
inject
vector
tumor
core
use
convect
enhanc
deliveri
use
method
result
high
distribut
volum
drug
vector
current
use
deliveri
method
clinic
studi
addit
tumor
model
appli
highli
invas
lack
sharpli
demarc
brain
tumornorm
brain
interfac
present
rat
glioma
model
anoth
explan
could
speci
differ
use
human
glioma
cell
studi
contrast
rat
glioma
cell
previou
work
vsvg
pseudotyp
vector
might
higher
tropism
human
glioma
cell
rat
normal
host
cell
howev
receptor
vsvg
unknown
remain
hypothesi
target
cancer
stem
cell
cancer
stemlik
cell
human
tumor
includ
glioblastoma
recent
evolv
major
aim
cancer
therapi
stem
cell
suggest
initi
cancer
might
resist
therapi
thu
respons
tumor
recurr
yet
recent
studi
initi
controversi
discuss
whether
cancer
stem
cell
realli
exist
therefor
use
term
cancer
stemlik
cell
studi
design
cell
certain
stemlik
properti
describ
previous
show
lentivir
vector
transduc
cell
cell
identifi
cancer
initi
cell
cancer
stem
cell
mani
differ
cancer
includ
glioblastoma
howev
recent
report
question
find
show
popopul
includ
cancer
initi
cell
well
effici
target
glioma
cell
also
describ
adenovir
vector
demonstr
sort
cell
tumor
transduc
either
lentivir
lcmvgp
vsvg
pseudotyp
lentivir
vector
abil
form
spheroid
upon
cultur
neural
basal
medium
supplement
egf
bfgf
spheroid
sort
cell
popul
express
neural
stem
cell
marker
nestin
show
abil
express
differenti
marker
gfap
btubuliniii
serum
condit
properti
describ
neural
progenitor
cell
well
cancer
stemlik
cell
human
glioblastoma
thu
cell
popul
transduc
lcmv
vsv
pseudotyp
lentivir
vector
show
featur
cancer
stemlik
cell
might
import
target
therapi
therapeut
approach
use
suicid
gene
fuse
egfp
demonstr
highli
signific
therapeut
effect
lentivir
vector
compar
control
group
use
mri
follow
tumor
growth
detect
complet
remiss
anim
lcmvgp
vsvg
pseudotyp
vector
day
ganciclovir
treatment
report
effect
therapeut
gene
previou
studi
limit
success
clinic
studi
result
ineffici
gene
deliveri
system
rather
lack
efficaci
suicid
mechan
howev
still
space
improv
prodrug
deliveri
applic
length
treatment
interv
rout
deliveri
tai
et
al
demonstr
multipl
cycl
prodrug
applic
superior
one
cycl
prodrug
studi
still
detect
gfpposit
tumor
cell
one
cycl
day
ganciclovir
administr
treat
anim
indic
applic
cycl
might
also
improv
therapeut
effect
set
result
demonstr
vectortransduc
tumor
cell
retain
abil
invad
brain
tissu
migrat
even
distant
brain
region
conclus
present
studi
demonstr
effici
transduct
therapi
experiment
human
glioblastoma
lentivir
vector
ineffici
gene
transfer
gammaretrovir
vector
line
result
obtain
clinic
trial
thu
confirm
high
relev
spheroidbas
glioma
anim
model
translat
research
